Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYBR CyberCare the new look of healthcare -- Ignore unavailable to you. Want to Upgrade?

To: sommovigo who wrote (2174)	6/16/2000 5:59:00 PM
From: R L	Read Replies (1) \| Respond to of 3392

sommovigo, You missed some of the news on CYBR today. regards, RL biz.yahoo.com Company Press Release The Pomerantz Firm Says Cyber-Care Violates Federal Securities Laws NEW YORK--(BUSINESS WIRE)--June 16, 2000--The following is an announcement by the law firm of Pomerantz Haudek Block Grossman & Gross LLP: Cyber-Care Inc (``Cyber-Care'' or the ``Company'') (Nasdaq:CYBR - news) and two of the Company's senior executives allegedly violated the Federal Securities laws by disseminating a series of materially false and misleading statements concerning the business and financial condition of Cyber-Care which served to inflate the price of the Company's stock during the period between October 12, 1999 and May 12, 2000, inclusive (the ``Class Period''), according to allegations in a complaint filed by Pomerantz Haudek Block Grossman & Gross LLP (www.pomerantzlaw.com) on behalf of all those who purchased the common stock or other securities of Cyber-Care during the Class Period. The Complaint further alleges that Cyber-Care misrepresented that its Internet based product, Electronic HouseCall System (``EHC''), was market ready, and that the Company had received contracts without disclosing that EHC was in the testing phase and had not received FDA approval, in violation of FDA rules. The FDA had not approved the EHC system for marketing or sale, and the purported orders were vague expressions of interest. As a result of Cyber-Care's materially false and misleading statements, the market price of the Company's common stock was artificially inflated during the Class period. When the market finally learned of the Company's misrepresentations, the price of Cyber-Care's common stock fell dramatically. If you purchased Cyber-Care common stock or other securities during the Class Period, you have until July 18, 2000 to ask the Court to appoint you as one of the lead plaintiffs for the Class. In order to serve as lead plaintiff, you must meet certain legal requirements. If you wish to discuss this action or have any questions, please contact Andrew G. Tolan, Esq. of the Pomerantz firm at 888-476-6529 (or (888) 4-POMLAW), toll free, or at agtolan@pomlaw.com by e-mail. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. -------------------------------------------------------------------------------- Contact: Pomerantz Haudek Block Grossman & Gross LLP Andrew G. Tolan, Esq., 888/476-6529 (888/4-POMLAW) agtolan@pomlaw.com